摘要 |
<p>PROBLEM TO BE SOLVED: To obtain a low mol.wt. VEGF(Vascular Endothelial cell Growth Factor) inhibitor capable of being utilized for the therapy of solid carcinoma and other vascularization-accompanying diseases. SOLUTION: This polypeptide comprising the first to third immunoglobulin- like domains, the first to fourth immunoglobulin-like domains or the first to fifth immunoglobulin-like domains in the extracellular region of a FLT acting as a VEGF receptor has a VEGF-inhibiting activity.</p> |